Landlocked developing countries (LLDCs) vs Portugal: Proportion of the target population … measles-containing-vaccine
Landlocked developing countries (LLDCs)
65.0%
in 2024
Portugal
96.0%
in 2024
Landlocked developing countries (LLDCs) rank
27th
Portugal rank
28th
Proportion of the target population … measles-containing-vaccine over time
- Landlocked developing countries (LLDCs)
- Portugal
How they compare
Portugal currently reports 96.0% against 65.0% in Landlocked developing countries (LLDCs), a difference of 31.0%.
That makes Portugal's figure about 1.5 times Landlocked developing countries (LLDCs)'s.
Across all 25 years both countries report, Portugal has been ahead every year.
Landlocked developing countries (LLDCs) ranks 27th and Portugal ranks 28th of 36 groups.
Portugal has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Landlocked developing countries (LLDCs) | Portugal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 11.9% | 78.6% | 66.7% | Portugal |
| 2010s | 26.7% | 95.6% | 68.9% | Portugal |
| 2020s | 56.4% | 95.4% | 39.0% | Portugal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received, Landlocked developing countries (LLDCs) or Portugal?
- Portugal, at 96.0% against 65.0% in Landlocked developing countries (LLDCs) as of 2024.
- What is the difference in proportion of the target population who received between Landlocked developing countries (LLDCs) and Portugal?
- 31.0%, with Portugal ahead.
- How many years of comparable data are there for Landlocked developing countries (LLDCs) and Portugal?
- 25 years are reported by both, from 2000 to 2024.
- How do Landlocked developing countries (LLDCs) and Portugal rank globally for proportion of the target population who received?
- Landlocked developing countries (LLDCs) ranks 27th and Portugal ranks 28th of 36 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.